← Cases
United StatesHealthcare and life sciences2025 – ongoing

Bristol Myers Squibb

Internal ChatGPT customized with company documentation

Bristol Myers Squibb reported about 16,000 users of its internal ChatGPT tool

WorkingCompany's own claim

Problem

Employees needed answers grounded in relevant company documentation, including curated prescribing information.

Approach

BMS used OpenAI models through Microsoft Azure and customized its internal tool with company documentation. Its technology chief described answers drawing on curated product information and IT helpdesk policies.

Results

about 16,000employees or active users of the internal tool, according to BMS technology chief Greg MeyersCompany's own claim[1]

Takeaway

The user count established uptake; BMS did not report measured time savings for this tool.

Categories

Innovation type
Process innovation
AI technology
Generative AI
Evidence
Company's own claim

Sources

  1. Predict First: BMS Executives Discuss Company's AI Approach
    Genetic Engineering & Biotechnology News26 Mar 2025News article

Source summaries

[1]Genetic Engineering & Biotechnology News26 Mar 2025

Greg Meyers described BMS's internal ChatGPT deployment using OpenAI through Azure. He reported about 16,000 employees or active users and explained how company documentation informed answers.

Full details are in the original sources.

Added 1 Nov 2026 · Updated 1 Nov 2026
Open case page ↗